Jack Nathan Medical Corp. JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -1.38M | -- | 6.11M | 15.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -1.38M | -- | 6.11M | 15.65M |
| Cost of Revenue | -- | -382.20K | -- | 937.10K | 3.46M |
| Gross Profit | -- | -1.00M | -- | 5.17M | 12.19M |
| SG&A Expenses | -- | -596.30K | -- | 6.66M | 16.42M |
| Depreciation & Amortization | -- | -241.00K | -- | 193.60K | 944.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -1.22M | -- | 7.79M | 20.75M |
| Operating Income | -- | -163.90K | -- | -1.68M | -5.11M |
| Income Before Tax | -- | -590.20K | -- | -1.76M | -6.70M |
| Income Tax Expenses | -- | -65.30K | -- | 11.30K | -520.30K |
| Earnings from Continuing Operations | -- | -0.52 | -- | -1.78 | -6.18 |
| Earnings from Discontinued Operations | -- | -395.80K | -- | 300.00 | 300.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 6.51M | -- | 5.26M | -6.18M |
| EBIT | -- | -163.90K | -- | -1.68M | -5.11M |
| EBITDA | -- | 94.80K | -- | -1.08M | -4.39M |
| EPS Basic | -- | 0.07 | -- | 0.06 | -0.07 |
| Normalized Basic EPS | -- | 0.00 | -- | -0.01 | -0.05 |
| EPS Diluted | -- | 0.07 | -- | 0.06 | -0.07 |
| Normalized Diluted EPS | -- | 0.00 | -- | -0.01 | -0.05 |
| Average Basic Shares Outstanding | -- | 348.40M | -- | 348.40M | 348.41M |
| Average Diluted Shares Outstanding | -- | 357.73M | -- | 357.73M | 357.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |